Editor’s Note: This article originally appeared on Premier’s website.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released its inflation estimates for contracted and non-contracted pharmaceutical pricing for fiscal year 2020 (July 2019 – June 2020), projecting a 3.8 percent increase in total pharmaceutical costs. This inflation rate is approximately 0.4 percent lower than Premier’s fiscal year 2019 projections.
“Premier’s superior pharmacy contracting team has been able to secure industry-leading pricing across our portfolio, saving our members millions over last year’s estimates,” said Michael J. Alkire, Chief Operating Officer, Premier. “As health systems face increasing financial pressures and compressing margins, we are thrilled to provide these savings to our members.” Click here to continue>>
News From Our Partners
